Beyond Air
Beyond Air, a medical device and biopharmaceutical company based in New York, has developed a nitric oxide generator and delivery system, the LungFit™, which is anticipated to be used in the treatment of patients with respiratory conditions and diseases, such as pulmonary hypertension and serious lung infections. The LungFit™ system consists of proprietary technology that generates nitric oxide from room air and delivers it to patients in a hospital setting who are ventilated or breathing spontaneously, or the home setting via a simple breathing circuit and mask.
Beyond Air recognized the need to provide a treatment for those suffering respiratory issues as a result of COVID-19. They are allocating significant resources to accelerate the LungFit™ COVID-19 program and recently reached an agreement with the FDA to test the system in a clinical study with COVID-19 patients. They are taking all necessary measures to quickly make this respiratory solution available so that healthcare providers have access to nitric oxide therapy as a potential treatment.
Learn more about Beyond Air’s LungFit™ BRO COVID-19 Program.
Explore Our Services
Contact Us
Get advice and answers from the TriNet team on the HR concerns you face.
Learn how TriNet’s comprehensive HR solutions can help your business.
For questions, contact:
6AM - 12AM EST, Monday - Friday
Founded in 1988 in the San Francisco Bay Area
Clients as of 12/31/22
Worksite employees as of 12/31/22